Skip to main content

StemPoint Capital LP

SEC CIK
0001952142
Latest filing
Aug 14, 2026

GLUE holding history

Monte Rosa Therapeutics, Inc. in every 13F filed by StemPoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GLUE overviewAll 13F holders of GLUEFull Q2 2026 holdings

Shares (Q2 2026)
153,544
Value
$3.72M
% of portfolio
0.6%
Quarters held
2
Since Q4 2025
Holdings of GLUE by StemPoint Capital LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026153,544$3.72M0.6%+153,544NewHolders
Q1 20260$00.0%−61,577−100.0%Sold outHolders
Q4 202561,577$965.5K0.2%+61,577NewHolders